Patents by Inventor Dimitra LOUKA

Dimitra LOUKA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DEXAMETHASONE PRODRUG COMPOSITIONS AND USES THEREOF
    Publication number: 20230225975
    Abstract: The disclosure features pharmaceutical compositions formed from prodrug dimers for the extended delivery of a drug and for the treatment of a disease or condition.
    Type: Application
    Filed: February 16, 2023
    Publication date: July 20, 2023
    Inventors: Ian Charles PARRAG, Matthew Alexander John STATHAM, Kyle BATTISTON, Dimitra LOUKA, Hans Christian FISCHER, J. Paul SANTERRE, Wendy Alison NAIMARK
  • INTRAVITREAL INJECTOR
    Publication number: 20230113525
    Abstract: Provided herein are needle assemblies for intravitreal injection of an implant into an eye of a patient through an unsheathed state and a sheathed state. Such needle assemblies are precise and accurate for proper treatment and prevent further damage to the eye.
    Type: Application
    Filed: September 1, 2022
    Publication date: April 13, 2023
    Inventors: Ian PARRAG, Hans FISCHER, Dimitra LOUKA, Jared A. DEMORAT, Robert William HENSON, Eli B. NICHOLS
  • Ocular inserts comprising a covalently linked steroid dimer
    Patent number: 11612567
    Abstract: The disclosure relates to compounds and compositions for sustained release of ocular therapeutics.
    Type: Grant
    Filed: February 1, 2019
    Date of Patent: March 28, 2023
    Assignee: RIPPLE THERAPEUTICS CORPORATION
    Inventors: Ian Charles Parrag, Matthew Alexander John Statham, Kyle Battiston, Dimitra Louka, Wendy Alison Naimark, Hans Christian Fischer, Leonard Pinchuk
  • INTRAVITREAL INJECTOR
    Publication number: 20220387213
    Abstract: Provided herein are needle assemblies for intravitreal injection of an (e.g., one or more) implant(s) into an eye of a patient through an unsheathed state and a sheathed state. Such needle assemblies are precise and accurate for proper treatment and prevent further damage to the eye.
    Type: Application
    Filed: October 20, 2020
    Publication date: December 8, 2022
    Inventors: Ian Charles PARRAG, Hans FISCHER, Dimitra LOUKA, Jared A. DEMORAT, Robert William HENSON, Eli B. NICHOLS
  • Intravitreal injector
    Patent number: 11464914
    Abstract: Provided herein are needle assemblies for intravitreal injection of an implant into an eye of a patient through an unsheathed state and a sheathed state. Such needle assemblies are precise and accurate for proper treatment and prevent further damage to the eye.
    Type: Grant
    Filed: February 21, 2020
    Date of Patent: October 11, 2022
    Assignee: RIPPLE THERAPEUTICS CORPORATION
    Inventors: Ian Parrag, Hans Fischer, Dimitra Louka, Jared A. Demorat, Robert William Henson, Eli B. Nichols
  • SURFACE COATINGS AND IMPLANTABLE DEVICES COMPRISING DIMERIC STEROID PRODRUGS, AND USES THEREOF
    Publication number: 20220288277
    Abstract: The disclosure features surface coatings formed from dimeric steroid prodrugs for the extended delivery of a drug from a surface, and for the treatment of a disease or condition. Also provided herein are drug depots formed from dimeric steroid prodrugs for the extended delivery of a drug for use in combination with implantable medical devices. Said dimeric steroid prodrugs are represented by the formula D1-L-D2, wherein D1 and D2 are independently a steroid radical and L is a linker covalently linking D1 to D2.
    Type: Application
    Filed: July 9, 2020
    Publication date: September 15, 2022
    Inventors: Ian Charles PARRAG, Matthew Alexander John STATHAM, Dimitra LOUKA, Kyle Giovanni BATTISTON, J. Paul SANTERRE, Wendy Alison NAIMARK, Bernadette ILAGAN, Gillian Claire MACKEY, Hans Christian FISCHER, Jamie Robert SWENOR, Kelli-Anne Nicole WOOTTON
  • DEXAMETHASONE PRODRUG COMPOSITIONS AND USES THEREOF
    Publication number: 20210205222
    Abstract: The disclosure features dexamethasone prodrug dimers of dexamethasone and pharmaceutical compositions thereof useful for, e.g., the extended release of a drug and for the treatment of a disease or condition.
    Type: Application
    Filed: January 8, 2021
    Publication date: July 8, 2021
    Inventors: Ian Charles PARRAG, Matthew Alexander John STATHAM, Kyle BATTISTON, Dimitra LOUKA, Hans Christian FISCHER, J. Paul SANTERRE, Wendy Alison NAIMARK, Roseita Esfand
  • INTRAVITREAL INJECTOR
    Publication number: 20210113780
    Abstract: Provided herein are needle assemblies for intravitreal injection of an implant into an eye of a patient through an unsheathed state and a sheathed state. Such needle assemblies are precise and accurate for proper treatment and prevent further damage to the eye.
    Type: Application
    Filed: February 21, 2020
    Publication date: April 22, 2021
    Inventors: Ian PARRAG, Hans FISCHER, Dimitra LOUKA, Jared A. DEMORAT, Robert William HENSON, Eli B. NICHOLS
  • GLASS FORMULATIONS AND USES THEREOF
    Publication number: 20210113457
    Abstract: The disclosure features pharmaceutical compositions formed from prodrug dimers for the extended delivery of a drug and for the treatment of a disease or condition.
    Type: Application
    Filed: February 1, 2019
    Publication date: April 22, 2021
    Inventors: Ian Charles PARRAG, Matthew Alexander John STATHAM, Kyle BATTISTON, Dimitra LOUKA, Hans Christian FISCHER, J. Paul SANTERRE, Wendy Alison NAIMARK
  • Dexamethasone prodrug compositions and uses thereof
    Patent number: 10959954
    Abstract: The disclosure features dexamethasone prodrug dimers of dexamethasone and pharmaceutical compositions thereof useful for, e.g., the extended release of a drug and for the treatment of a disease or condition.
    Type: Grant
    Filed: November 27, 2019
    Date of Patent: March 30, 2021
    Assignee: RIPPLE THERAPEUTICS CORPORATION
    Inventors: Ian Charles Parrag, Matthew Alexander John Statham, Kyle Battiston, Dimitra Louka, Hans Christian Fischer, J. Paul Santerre, Wendy Alison Naimark, Roseita Esfand
  • Dexamethasone prodrug compositions and uses thereof
    Patent number: 10945958
    Abstract: The disclosure features dexamethasone prodrug dimers of dexamethasone and pharmaceutical compositions thereof useful for, e.g., the extended release of a drug and for the treatment of a disease or condition.
    Type: Grant
    Filed: November 29, 2019
    Date of Patent: March 16, 2021
    Assignee: RIPPLE THERAPEUTICS CORPORATION
    Inventors: Ian Charles Parrag, Matthew Alexander John Statham, Kyle Battiston, Dimitra Louka, Hans Christian Fischer, J. Paul Santerre, Wendy Alison Naimark
  • OCULAR INSERTS COMPRISING A COVALENTLY LINKED STEROID DIMER
    Publication number: 20210030667
    Abstract: The disclosure relates to compounds and compositions for sustained release of ocular therapeutics.
    Type: Application
    Filed: February 1, 2019
    Publication date: February 4, 2021
    Inventors: Ian Charles PARRAG, Matthew Alexander John STATHAM, Kyle BATTISTON, Dimitra LOUKA, Wendy Alison NAIMARK, Hans Christian FISCHER, Leonard PINCHUK
  • Glass formulations and uses thereof
    Patent number: 10632075
    Abstract: The disclosure features pharmaceutical compositions formed from prodrug dimers for the extended delivery of a drug and for the treatment of a disease or condition.
    Type: Grant
    Filed: April 26, 2019
    Date of Patent: April 28, 2020
    Assignee: Ripple Therapeutics Corporation
    Inventors: Ian Charles Parrag, Matthew Alexander John Statham, Kyle Battiston, Dimitra Louka, Hans Christian Fischer, J. Paul Santerre, Wendy Alison Naimark
  • DEXAMETHASONE PRODRUG COMPOSITIONS AND USES THEREOF
    Publication number: 20200113834
    Abstract: The disclosure features dexamethasone prodrug dimers of dexamethasone and pharmaceutical compositions thereof useful for, e.g., the extended release of a drug and for the treatment of a disease or condition.
    Type: Application
    Filed: November 29, 2019
    Publication date: April 16, 2020
    Inventors: Ian Charles PARRAG, Matthew Alexander John STATHAM, Kyle BATTISTON, Dimitra LOUKA, Hans Christian FISCHER, J. Paul SANTERRE, Wendy Alison NAIMARK
  • DEXAMETHASONE PRODRUG COMPOSITIONS AND USES THEREOF
    Publication number: 20200113833
    Abstract: The disclosure features dexamethasone prodrug dimers of dexamethasone and pharmaceutical compositions thereof useful for, e.g., the extended release of a drug and for the treatment of a disease or condition.
    Type: Application
    Filed: November 27, 2019
    Publication date: April 16, 2020
    Inventors: Ian Charles PARRAG, Matthew Alexander John STATHAM, Kyle BATTISTON, Dimitra LOUKA, Hans Christian FISCHER, J. Paul SANTERRE, Wendy Alison NAIMARK
  • Dexamethasone prodrug compositions and uses thereof
    Patent number: 10588862
    Abstract: The disclosure features dexamethasone prodrug dimers of dexamethasone and pharmaceutical compositions thereof useful for, e.g., the extended release of a drug and for the treatment of a disease or condition.
    Type: Grant
    Filed: April 26, 2019
    Date of Patent: March 17, 2020
    Assignee: Ripple Therapeutics Corporation
    Inventors: Ian Charles Parrag, Matthew Alexander John Statham, Kyle Battiston, Dimitra Louka, Hans Christian Fischer, J. Paul Santerre, Wendy Alison Naimark
  • GLASS FORMULATIONS AND USES THEREOF
    Publication number: 20190275167
    Abstract: The disclosure features pharmaceutical compositions formed from prodrug dimers for the extended delivery of a drug and for the treatment of a disease or condition.
    Type: Application
    Filed: April 26, 2019
    Publication date: September 12, 2019
    Inventors: Ian Charles PARRAG, Matthew Alexander John STATHAM, Kyle BATTISTON, Dimitra LOUKA, Hans Christian FISCHER, J. Paul SANTERRE, Wendy Alison NAIMARK
  • DEXAMETHSONE PRODRUG COMPOSITIONS AND USES THEREOF
    Publication number: 20190247311
    Abstract: The disclosure features dexamethasone prodrug dimers of dexamethasone and pharmaceutical compositions thereof useful for, e.g., the extended release of a drug and for the treatment of a disease or condition.
    Type: Application
    Filed: April 26, 2019
    Publication date: August 15, 2019
    Inventors: Ian Charles PARRAG, Matthew Alexander John STATHAM, Kyle BATTISTON, Dimitra LOUKA, Hans Christian FISCHER, J. Paul SANTERRE, Wendy Alison NAIMARK